An Open-Label Rollover Study of PBI-4050 in Subjects with Alström Syndrome - A Rollover Study of PBI-4050 in Subjects with Alström Syndrome
A Phase 2, Single-Arm, Open-Label Study to Evaluate the Safety and Tolerability of PBI-4050 and of its Effects on the Inflammatory, Fibrosis,Diabetes and Obesity Biomarkers in Subjects with Alström Syndrome - Phase II Study of PBI-4050 in Subjects with Alström Syndrome
100 项与 ProMetic Biosciences (USA), Inc. 相关的临床结果
0 项与 ProMetic Biosciences (USA), Inc. 相关的专利（医药）
100 项与 ProMetic Biosciences (USA), Inc. 相关的药物交易
100 项与 ProMetic Biosciences (USA), Inc. 相关的转化医学
